Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis

被引:1
|
作者
Patil, Rajashri [1 ]
Mukhida, Sahjid [1 ]
Ajagunde, Jyoti [1 ]
Khan, Uzair [1 ]
Khan, Sameena [1 ]
Gandham, Nageswari [1 ]
Vyawhare, Chanda [1 ]
Das, Nikunja K. [1 ]
Mirza, Shahzad [1 ]
机构
[1] Dr DY Patil Vidyapeeth, Dr DY Patil Med Coll Hosp & Res Ctr, Dept Microbiol, Pune 18, India
关键词
COVID-19-associated mucormycosis; machine learning; mucormycosis; rhino-orbito-cerebral mucormycosis;
D O I
10.2217/fmb-2023-0190
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Aim: The study aimed to identify quantitative parameters that increase the risk of rhino-orbito-cerebral mucormycosis, and subsequently developed a machine learning model that can anticipate susceptibility to developing this condition. Methods: Clinicopathological data from 124 patients were used to quantify their association with COVID-19-associated mucormycosis (CAM) and subsequently develop a machine learning model to predict its likelihood. Results: Diabetes mellitus, noninvasive ventilation and hypertension were found to have statistically significant associations with radiologically confirmed CAM cases. Conclusion: Machine learning models can be used to accurately predict the likelihood of development of CAM, and this methodology can be used in creating prediction algorithms of a wide variety of infections and complications. Fungal infections caused by the Mucorales order of fungi usually target patients with a weakened immune system. They are usually also associated with abnormal blood sugar states, such as in diabetic patients. Recent work during the COVID-19 outbreak suggested that excessive steroid use and diabetes may be behind the rise in fungal infections caused by Mucorales, known as mucormycosis, in India, but little work has been done to see whether we can predict the risk of mucormycosis. This study found that these fungal infections need not necessarily be caused by Mucorales species, but by a wide variety of fungi that target patients with weak immune systems. Secondly, we found that diabetes, breathing-assisting devices and high blood pressure states had associations with COVID-19-associated fungal infections. Finally, we were able to develop a machine learning model that showed high accuracy when predicting the risk of development of these fungal infections.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 50 条
  • [41] Development of nanozymes for promising alleviation of COVID-19-associated arthritis
    Li, Dan
    Zhao, Baofeng
    Zhuang, Pengfei
    Mei, Xifan
    BIOMATERIALS SCIENCE, 2023, 11 (17) : 5781 - 5796
  • [42] Impact of COVID-19-Associated AKI on Subsequent Development of CKD
    Mohamed, Muner
    Dwal, Ashraf
    Velez, Juan Carlos Q.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 62 - 62
  • [43] Iranian patients with diabetes and COVID-19-associated mucormycosis: Characteristics, manifestations, and mortality risk factors
    Salehi, Mohammadreza
    Esteghamati, Alireza
    Khodavaisy, Sadegh
    Khajavi Rad, Nasim
    Abdollahi, Alireza
    Alemzadeh, Sayyed Amirsina
    Nasserisina, Sadaf
    Tabari, Azin
    Pakdel, Farzad
    Mohammadi, Saeed
    Joorabloo, Neda
    Abdorahimi, Mahsa
    Shavandi, Mehrdad
    Rabizadeh, Soghra
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (04) : 704 - 710
  • [44] Pulmonary Mucormycosis: Beyond Classic COVID-19-Associated Fungal Infections
    Pereira, Rita
    Neves, Sara
    Ruao, Maria
    Goncalves, Celina
    Teixeira, Carla
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [45] An Observational Study on Impact of Interim Obturators in COVID-19-Associated Mucormycosis
    Chittamuru, Narendra Reddy
    Vengamma, B.
    Priya, P. Vani
    Babu, D. S. Madhu
    Mohan, Alladi
    Rapur, Ram
    JOURNAL OF MAXILLOFACIAL & ORAL SURGERY, 2024,
  • [46] Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021
    Arora, Shitij
    Hemmige, Vagish S.
    Mandke, Charuta
    Chansoria, Mayank
    Rawat, Sumit Kumar
    Dravid, Ameet
    Sethi, Yatin
    Medikeri, Gaurav
    Jariwala, Sunit P.
    Puius, Yoram A.
    EMERGING INFECTIOUS DISEASES, 2021, 27 (11) : 2963 - 2965
  • [47] Black Fungus of the Foot An Unusual Presentation of COVID-19-Associated Mucormycosis
    Russo, Ashley T.
    Buffolino, Raffaella
    Shvartsbeyn, Marianna
    Meehan, Shane A.
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2024, 114 (01)
  • [48] COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality
    Valliappan Muthu
    Ritesh Agarwal
    Arunaloke Chakrabarti
    Mycopathologia, 2022, 187 : 405 - 406
  • [49] Effectiveness of hyperbaric oxygen therapy in the management of COVID-19-associated mucormycosis
    Pandey, Sandhya
    Kumar, Vijay
    Kumar, Ravi
    Mishra, Brijesh
    Singh, Anshu
    Reddy, Gowtham
    MEDICAL GAS RESEARCH, 2024, 14 (02): : 87 - 88
  • [50] COVID-19-Associated Mucormycosis - Arkansas, July-September 2021
    Dulski, Theresa M.
    DeLong, Megan
    Garner, Kelley
    Patil, Naveen
    Cima, Michael J.
    Rothfeldt, Laura
    Gulley, Trent
    Porter, Austin
    Vyas, Keyur S.
    Liverett, Hazel K.
    Toda, Mitsuru
    Gold, Jeremy A. W.
    Kothari, Atul
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (50): : 1750 - 1751